Results 121 to 130 of about 9,505,976 (163)

Deficiency of GLUT1 in macrophages reprograms tumor-associated macrophages to normalize tumor vasculature and retards the progression of tumors. [PDF]

Int J Biol Sci
Fang Y, Zou W, Ning L, Li T, Huang Y, Song X, Gao M, Jia R, Zhu M, Qiu W, Liu K, Wang A, Li J, Lu Y, Zhao Y.   +14 more
europepmc   +1 more source

Spatial single-cell landscape of tumor-associated macrophages and their crosstalk with the tumor microenvironment. [PDF]

Cell Discov
Nie RC, Hu GS, Cao SQ, Wang A, Wang DC, Liu W.   +5 more
europepmc   +1 more source

Traditional Chinese medicine modulates tumor-associated macrophages to suppress gastric cancer progression: mechanisms and therapeutic potential. [PDF]

Front Oncol
Zhuang X, Yang Q, Huang L, Liu R, Ma T, Guan L, Zheng Y.   +6 more
europepmc   +1 more source

COLEC12high tumor-associated macrophages: A novel paracrine axis driving lenvatinib resistance in hepatocellular carcinoma: Editorial on "COLEC12high tumor-associated macrophages orchestrate lenvatinib resistance and cancer stemness in hepatocellular carcinoma via paracrine NRG1-HER2/HER3 signaling". [PDF]

Clin Mol Hepatol
Han JW.
europepmc   +1 more source

A Pancreatitis-Inspired Trypsinogen Nanoplatform Reprograms Tumor-Associated Macrophages via NF-κB for Pancreatic Cancer Immunotherapy. [PDF]

Adv Sci (Weinh)
Cao L, He Y, Li W, Gong B, Lin H, Shi J, Yong Y, Wu W.   +7 more
europepmc   +1 more source

Progastrin, annexin A2, and tumor-associated macrophages in gastric adenocarcinoma. [PDF]

J Pathol Transl Med
Christofidis K, Fioretzaki R, Papoudas SM, Charalampakis N, Kavantzas N, Schizas D, Sakellariou S.   +6 more
europepmc   +1 more source

FOXP1 transcriptionally activates NUSAP1 to induce M2 polarization of tumor-associated macrophages via glycolysis in hepatocellular carcinoma. [PDF]

Front Genet
Wang Z, Mao Y, Wang J, Yu Y, Shao J, Fei Y, Zhu J, Tong M.   +7 more
europepmc   +1 more source

Tumor-Associated Macrophages in Hepatocellular Carcinoma: From Ontogeny and Heterogeneity to Immune Evasion and Therapeutic Targeting. [PDF]

J Hepatocell Carcinoma
Su Y, Liang Y, Zhong D, Chen Y, Ma SS, Huang X.   +5 more
europepmc   +1 more source